Antisense compounds and uses thereof
AssigneeIonis Pharmaceuticals, Inc.
InventorsErich Koller, Aaron J. Donner, Punit P. Seth, C. Frank Bennett
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for sensitizing a cell for modulation by oligomeric compounds. Certain such oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited, to nucleic acids in a cell. In certain embodiments, hybridization results in modulation of the amount activity or expression of the target nucleic acid in a cell.
Claims38
1-2. (canceled)
A method of reducing the amount or activity of a target nucleic acid in a liver cell comprising first contacting the liver cell with fingolimod, and subsequently contacting the cell with an oligomeric compound;
- and thereby reducing the amount or activity of the target nucleic acid in a the liver cell.
6-7. (canceled)
11-14. (canceled)
18-20. (canceled)
(canceled)
26-32. (canceled)
37-39. (canceled)
42-47. (canceled)
49-50. (canceled)
52-53. (canceled)
55-61. (canceled)
64-66. (canceled)
68-69. (canceled)
Dependencies are inferred from the claim text.